Hilton Pryce Lewis, Co-founder, President and CEO, GVD Corporation
Interpretable AI co-founders, Jack Dunn and Daisy Zhuo
Emilio Frazzoli, MIT Professor of Aeronautics & Astronautics, nuTonomy CTO
"Trends in Wellness Investments", David T. Thibodeau, Managing Director, Wellvest Capital
Matthew Osman, Legit
Synthetic Biology Workshop 2017 - Panel Discussion
Scalable production of RNA for agriculture Andrey Zarur, Cofounder & CEO, GreenLight Biosciences Potassium fertilizer innovation Philip Wender, Managing Director, Advanced Potash Technologies Chemiresistive gas sensing for food safety Merry Smith, Senior Scientist, C2Sense Novel dehumidifying material for indoor farms Sorin Grama, Cofounder, Transaera Probiotics for plants Michael Miille, CEO, Joyn Bio [Joyn is a JV between Ginkgo Bioworks and Leaps by Bayer]
Trond Undheim, PhD, Program Director, MIT Startup Exchange; Paula Hammond, PhD, David H. Koch Professor in Engineering and Department Head, Chemical Engineering, MIT; Laura Indolfi, PhD, CEO of PanTher Therapeutics; Peter Sandor, VP, Head of Oncology Marketing Strategy, Astellas.
Dilip Sundaram - Corporate Keynote
Max Kanter, Cofounder & CEO, Feature Labs